Stocks and Investing Stocks and Investing
Tue, May 14, 2024

Cory Kasimov Initiated (BMRN) at Buy and Held Target at $113 on, May 14th, 2024


Published on 2024-10-28 11:20:04 - WOPRAI, Cory Kasimov
  Print publication without navigation


Cory Kasimov of Evercore ISI Group, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $113 on, May 14th, 2024.

Cory has made no other calls on BMRN in the last 4 months.



There are 9 other peers that have a rating on BMRN. Out of the 9 peers that are also analyzing BMRN, 4 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Decreased Target to $89 on, Friday, April 26th, 2024
  • David Lebovitz of "Citigroup" Maintained at Hold with Decreased Target to $91 on, Thursday, April 25th, 2024
  • George Farmer of "Scotiabank" Maintained at Hold with Increased Target to $85 on, Thursday, April 25th, 2024
  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Friday, February 23rd, 2024


These are the ratings of the 5 analyists that currently disagree with Cory


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $112 on, Friday, April 26th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $110 on, Thursday, April 25th, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Thursday, April 25th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $107 on, Friday, February 23rd, 2024
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $104 on, Tuesday, January 30th, 2024

Contributing Sources